Stockscreener 앱 받기
73.18
0.34%
0.25
시장 영업 전:
73.64
0.46
+0.63%
전일 마감가:
$72.93
열려 있는:
$72.93
하루 거래량:
3.17M
Relative Volume:
1.47
시가총액:
$8.56M
수익:
$947.36M
순이익/손실:
$392.47M
주가수익비율:
24.23
EPS:
3.02
순현금흐름:
$392.71M
1주 성능:
+2.88%
1개월 성능:
+25.65%
6개월 성능:
+26.83%
1년 성능:
+15.79%
1일 변동 폭
$72.93
$74.07
1주일 범위
$70.32
$74.07
52주 변동 폭
$42.01
$74.07
Halozyme Therapeutics Inc Stock (HALO) Company Profile
명칭
Halozyme Therapeutics Inc
전화
(858) 794-8889
주소
12390 EL CAMINO REAL, SAN DIEGO, CA
HALO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HALO
Halozyme Therapeutics Inc
|
73.18 | 8.53B | 947.36M | 392.47M | 392.71M | 3.02 |
|
VRTX
Vertex Pharmaceuticals Inc
|
389.08 | 99.27B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
586.96 | 62.28B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.18 | 59.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
707.96 | 43.34B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
300.14 | 36.72B | 3.81B | -644.79M | -669.77M | -6.24 |
Halozyme Therapeutics Inc Stock (HALO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-06 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2025-07-10 | 재개 | Goldman | Neutral |
| 2025-05-14 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2025-05-13 | 다운그레이드 | Leerink Partners | Market Perform → Underperform |
| 2024-10-07 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2024-09-19 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-06-07 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2024-02-29 | 개시 | TD Cowen | Outperform |
| 2023-07-24 | 다운그레이드 | Goldman | Buy → Neutral |
| 2023-07-24 | 개시 | H.C. Wainwright | Buy |
| 2023-05-10 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2023-03-27 | 재개 | Berenberg | Buy |
| 2023-03-16 | 다운그레이드 | SVB Securities | Outperform → Market Perform |
| 2022-12-21 | 재개 | Morgan Stanley | Overweight |
| 2022-11-28 | 개시 | Wells Fargo | Overweight |
| 2022-09-09 | 개시 | Morgan Stanley | Overweight |
| 2022-05-23 | 개시 | SVB Leerink | Outperform |
| 2021-06-14 | 개시 | Evercore ISI | Outperform |
| 2021-05-17 | 개시 | SVB Leerink | Outperform |
| 2021-05-11 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2021-01-21 | 재확인 | The Benchmark Company | Buy |
| 2020-12-17 | 개시 | Berenberg | Buy |
| 2020-09-14 | 재개 | JP Morgan | Overweight |
| 2020-07-01 | 개시 | The Benchmark Company | Buy |
| 2020-02-05 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2020-01-09 | 업그레이드 | BMO Capital Markets | Market Perform → Outperform |
| 2020-01-08 | 개시 | Goldman | Buy |
| 2019-11-05 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2018-10-19 | 재개 | Piper Jaffray | Neutral |
| 2018-05-11 | 다운그레이드 | Barclays | Equal Weight → Underweight |
| 2018-01-24 | 개시 | Goldman | Neutral |
| 2017-10-16 | 재확인 | Piper Jaffray | Overweight |
| 2017-01-06 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2016-11-03 | 개시 | Deutsche Bank | Buy |
| 2015-12-04 | 개시 | Wells Fargo | Outperform |
| 2015-11-18 | 개시 | Citigroup | Buy |
| 2015-09-22 | 개시 | Barclays | Overweight |
| 2015-06-22 | 재확인 | JP Morgan | Overweight |
| 2015-03-03 | 재확인 | UBS | Buy |
| 2015-02-18 | 재확인 | MLV & Co | Buy |
| 2015-01-08 | 재확인 | MLV & Co | Buy |
모두보기
Halozyme Therapeutics Inc 주식(HALO)의 최신 뉴스
What’s next for Halozyme Therapeutics Inc. stock priceJuly 2025 Decliners & Advanced Technical Signal Analysis - Newser
Halozyme Therapeutics Inc. stock volume spike explainedWeekly Trend Report & Smart Swing Trading Alerts - Newser
Applying Wyckoff theory to Halozyme Therapeutics Inc. stockPortfolio Performance Report & High Accuracy Buy Signal Tips - Newser
Real time social sentiment graph for Halozyme Therapeutics Inc.Risk Management & Weekly Chart Analysis and Trade Guides - Newser
What to expect from Halozyme Therapeutics Inc. in the next 30 days2025 Market Overview & Free Accurate Trade Setup Notifications - Newser
Visual trend scoring systems applied to Halozyme Therapeutics Inc.Quarterly Growth Report & Expert Approved Momentum Ideas - Newser
Published on: 2025-08-27 10:40:29 - Newser
Is Halozyme Therapeutics Inc. stock ready for a breakoutJuly 2025 Setups & Risk Managed Investment Signals - Newser
Is a relief rally coming for Halozyme Therapeutics Inc. holdersWeekly Profit Analysis & Reliable Entry Point Trade Alerts - Newser
Here's Why Halozyme Therapeutics (HALO) is a Strong Momentum Stock - Yahoo Finance
Halozyme Therapeutics stock reaches all-time high at 73.5 USD - Investing.com
Real time pattern detection on Halozyme Therapeutics Inc. stockPortfolio Growth Summary & Momentum Based Trading Signals - Newser
Trend analysis for Halozyme Therapeutics Inc. this weekJuly 2025 WrapUp & Accurate Trade Setup Notifications - Newser
Is New CMS Drug Pricing Guidance Changing the Long-Term Growth Outlook for Halozyme Therapeutics (HALO)? - Yahoo Finance
Quantitative breakdown of Halozyme Therapeutics Inc. recent move2025 Price Targets & Long-Term Capital Growth Strategies - Newser
Will Halozyme Therapeutics Inc. outperform the marketWeekly Profit Summary & Fast Moving Stock Watchlists - Newser
Real time breakdown of Halozyme Therapeutics Inc. stock performanceTrade Entry Summary & Verified Short-Term Plans - Newser
What moving averages say about Halozyme Therapeutics Inc.Gap Down & Stock Timing and Entry Methods - Newser
What candlestick patterns are forming on Halozyme Therapeutics Inc.2025 Trading Volume Trends & Safe Entry Zone Tips - Newser
Using data models to predict Halozyme Therapeutics Inc. stock movementJuly 2025 Spike Watch & Weekly Top Performers Watchlists - Newser
Halozyme Therapeutics Inc. stock prediction for this weekProfit Target & Growth Focused Entry Point Reports - Newser
What makes Halozyme Therapeutics Inc. stock price move sharply getLinesFromResByArray error: size == 0 - 더경남뉴스
Smart tools for monitoring Halozyme Therapeutics Inc.’s price actionEarnings Overview Report & Low Drawdown Trading Techniques - Newser
Acumen Pharmaceuticals to Participate in Upcoming Investor Conferences - GlobeNewswire Inc.
Halozyme Therapeutics Inc. recovery potential after sell offBear Alert & Safe Entry Point Identification - Newser
Forecasting Halozyme Therapeutics Inc. price range with options dataWeekly Trading Summary & Expert Verified Movement Alerts - Newser
Analyzing drawdowns of Halozyme Therapeutics Inc. with statistical toolsQuarterly Earnings Report & Weekly Market Pulse Updates - Newser
Halozyme Therapeutics (HALO) Fell Despite Reporting Strong Earnings and Improved Guidance - Yahoo Finance
Halozyme’s Big Q2 Raises Guidance - San Diego Business Journal
Published on: 2025-08-25 05:01:34 - Newser
Real time social sentiment graph for Halozyme Therapeutics Inc2025 Sector Review & Fast Exit/Entry Strategy Plans - Newser
Visual analytics tools that track Halozyme Therapeutics Inc. performanceGDP Growth & Pattern Based Trade Signal System - Newser
Halozyme Therapeutics Inc. stock outlook for YEAR2025 AllTime Highs & Weekly Top Gainers Trade List - Newser
Volatility clustering patterns for Halozyme Therapeutics Inc.July 2025 Final Week & Community Consensus Stock Picks - Newser
Is Halozyme Therapeutics Inc. stock entering bullish territoryBull Run & Free Weekly Watchlist of Top Performers - Newser
Halozyme Therapeutics Inc. stock chart pattern explainedJuly 2025 Weekly Recap & Fast Momentum Entry Tips - Newser
Halozyme Therapeutics, Inc. (NASDAQ:HALO) Stock Rockets 27% But Many Are Still Ignoring The Company - simplywall.st
Regression Model Predicts Rangebound Movement in Halozyme Therapeutics Inc.July 2025 Intraday Action & Low Risk High Win Rate Picks - beatles.ru
Halozyme Therapeutics Inc (HALO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.98%
8.06%
자본화:
|
볼륨(24시간):